COVID Bivalent Booster Falls Flat in First ‘Real-World’ Test, CDC Report Shows
www.thepulse.one
In September, the U.S. Food and Drug Administration (FDA) — over the objections of the agency’s own advisors — authorized Pfizer’s COVID-19 bivalent booster on an emergency basis, without any testing or demonstration that the products had any benefit in human beings.
COVID Bivalent Booster Falls Flat in First ‘Real-World’ Test, CDC Report Shows
COVID Bivalent Booster Falls Flat in First…
COVID Bivalent Booster Falls Flat in First ‘Real-World’ Test, CDC Report Shows
In September, the U.S. Food and Drug Administration (FDA) — over the objections of the agency’s own advisors — authorized Pfizer’s COVID-19 bivalent booster on an emergency basis, without any testing or demonstration that the products had any benefit in human beings.